Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
In two open-label trials, nirmatrelvir–ritonavir did not reduce the incidence of hospitalization or death among vaccinated higher-risk participants with SARS-CoV-2 infection.
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial
In adults living with severe obesity, RIV elicited stronger short-term humoral immune responses than an egg-based standard-dose vaccine, suggesting potential additional benefit for influenza prevention in this vulnerable population.
Influenza vaccination attenuates acute myocardial infarction and stroke risk following influenza infection: a register-based, self-controlled case series study, Denmark, 2014 to 2025
Influenza infection conferred a transiently increased risk of first-time AMI and stroke. Vaccination substantially attenuated this risk, supporting its role in preventing cardiovascular complications after breakthrough infection.
Respiratory viral infections prime accelerated lung cancer growth
The COVID-19 pandemic has highlighted the long-term consequences of viral pneumonia, yet its impact on cancer development remains unclear.
Cardiovascular disease related to influenza infection and the protective role of influenza vaccination
Influenza vaccination significantly reduces major adverse cardiovascular events and mortality across high-risk cardiac populations.
Risk of Alzheimer Dementia After High-Dose vs Standard-Dose Influenza Vaccination
Previous studies, including large cohort analyses comparing vaccinated and unvaccinated adults, suggest that routine immunizations such as inactivated influenza vaccines (IIVs) may reduce Alzheimer dementia (AD) risk.
News
Policy & Recommendations
Respiratory infections and long-term illness: a two-way street
The IDC kick-off meeting on 5 March was featured on the Vaccines Today news website.
News
Policy & Recommendations
Europe needs a Life Course Immunisation Strategy
‘A public health call to action: Europe needs a coordinated approach to ensure vaccination coverage at all stages of life, writes Professor Stefania Maggi.
